Centers for Disease Control and Prevention (CDC), Procurement & Grants Office, 255 East Paces Ferry Road, N.E., Room No. 507 Atlanta, Georgia 30305

B -- ASSESSMENT OF LABORATORY PERFORMANCE AND PRACTICES FOR DIRECT DETECTION OF MTB IN PATIENT SPECIMENS USING FDA APPROVED TEST KITS FOR THE AMPLIFICATION AND DETECTION OF MTB NUCLEIC ACIDS SOL 200-96-0527(P) DUE 080996 POC Contact Lorenzo J. Falgiano, Contract Specialist at (404)842-6786 The Centers for Disease Control and Prevention contemplates awarding a contract to assess the quality of performance of laboratories and/or individual commercial tests which use nucleic acid amplification techniques for the detection of MTB in patient specimens. In an effort to assess the quality and effectiveness of laboratory testing, an integral part of CDC's mandate to support broad public health goals which include surveillance prevention and treatment programs. CDC is interested in assessing both the performances and practices in laboratories that use amplification tests for detection of MTB. The period of performance shall be 30 months from the contract award date, and the Government anticipates making award prior to September 30, 1996, based on the availability of fiscal year 96 funds. No telephone requests will be accepted; only written requests for this solicitation will be honored. Written requests may be faxed to (404) 842-6727 citing RFP No. 200-96-0527(P). All responsible sources that meet the above requirements may submit a proposal which shall be considered by the Agency. (0151)

Loren Data Corp. http://www.ld.com (SYN# 0019 19960531\B-0003.SOL)